Tiban M 20/1000mg Tablet ER
By Tiban M
Rx
15 Tablet ER in a Strip

Composition
Metformin(1000mg) + Teneligliptin(20mg)

Manufacturer - Ajanta Pharma Ltd
Ajanta House, Charkop, Kandivli West, Mumbai 400 067, India

Expires on or after
August, 2025

liver
It is important to note that Tiban M 20/1000mg Tablet ER may not be safe for individuals with liver disease and should be avoided. It is recommended to consult with your doctor before using this medication to ensure your safety and appropriate treatment.

kidney
Tiban M 20/1000mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment may be necessary and it is not recommended in severe kidney disease. Regular kidney function test monitoring is advised during treatment. Consult your doctor for guidance.

alcohol
It is unsafe to drink alcohol while taking Tiban M 20/1000mg Tablet ER. Avoid alcohol consumption during this medication. Consult your doctor about alcohol use with Tiban M 20/1000mg Tablet ER.

driving
It is uncertain if Tiban M 20/1000mg Tablet ER affects driving ability. Avoid driving if symptoms impact focus and reaction time.

pregnancy
Tiban M 20/1000mg Tablet ER may not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for evaluation of benefits and risks before use.

breastfeeding
Caution Tiban M 20/1000mg Tablet ER is possibly unsafe during breastfeeding. Limited data shows the drug may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹286
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024